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Available online 29 February 2008Previously we demonstrated that insulin protects against neuronal oxidative stress by restoring antioxidants
and energy metabolism. In this study, we analysed how insulin inﬂuences insulin- (IR) and insulin growth
factor-1 receptor (IGF-1R) intracellular signaling pathways after oxidative stress caused by ascorbate/Fe2+ in
rat cortical neurons. Insulin prevented oxidative stress-induced decrease in tyrosine phosphorylation of IR
and IGF-1R and Akt inactivation. Insulin also decreased the active form of glycogen synthase kinase-3β (GSK-
3β) upon oxidation. Since phosphatidylinositol 3-kinase (PI-3K)/Akt-mediated inhibition of GSK-3β may
stimulate protein synthesis and decrease apoptosis, we analysed mRNA and protein expression of “candidate”
proteins involved in antioxidant defense, glucose metabolism and apoptosis. Insulin prevented oxidative
stress-induced increase in glutathione peroxidase-1 and decrease in hexokinase-II expression, supporting
previous ﬁndings of changes in glutathione redox cycle and glycolysis. Moreover, insulin precluded Bcl-2
decrease and caspase-3 increased expression. Concordantly, insulin abolished caspase-3 activity and DNA
fragmentation caused by oxidative stress. Thus, insulin-mediated activation of IR/IGF-1R stimulates PI-3K/Akt
and inhibits GSK-3β signaling pathways, modifying neuronal antioxidant defense-, glucose metabolism- and
anti-apoptotic-associated protein synthesis. These and previous data implicate insulin as a promising
neuroprotective agent against oxidative stress associated with neurodegenerative diseases.
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In the central nervous system (CNS), insulin binding and activation
of IR and/or IGF-1R [1] initiate a cascade of intracellular signaling
pathways that regulate brain activity [2]. Peripherally synthesized
insulin can be transported into the brain either via the blood–brain
barrier, or directly through the area postrema [3]. In addition, insulin
can be synthesized de novo in the brain, as deduced from the ob-
servation of preproinsulin I and II mRNA and insulin immunoreactivity
in neurons [4,5].
IR and IGF-1Rexpressionhas beenalsodetected in theCNS [5]. Insulin
binds to the IR with higher afﬁnity (b1 nM) than IGF-1 (100–500-fold
lower afﬁnity), whilst IGF-1 (b1 nM) preferentially binds IGF-1R
compared to insulin (100–500-fold lower afﬁnity) [6]. Binding of insulin
to the α subunits of IR or IGF-1R results in Tyr autophosphorylation of
β subunits, stimulating its Tyr kinase activity [7]. This then activates
phosphatidylinositol 3-kinase (PI-3K) and the Ser/Thr kinase Akt [8,9].
Phosphorylated (active) Akt has a prosurvival role against neuronalaculty of Medicine, Center for
04-504 Coimbra, Portugal. Tel.:
l rights reserved.apoptosis due to the phosphorylation and subsequent inactivation of
proapoptotic proteins, such as Bad, caspase-9 and FoxO1 [9]. Akt also
promotes glycogen synthase kinase-3β (GSK-3β) phosphorylation at
Ser9, inhibiting its activity [10]. cAMP response-element binding (CREB)-
induced expression of the anti-apoptotic protein Bcl-2 can also be
activated [11]. IR/IGF-1R-induced signaling may also activate Ras, Raf,
MEK (MAPK, mitogen-activated protein kinase) and ERK1/2 (extracel-
lular signal-regulated kinase), which control gene expression [9].
High content of polyunsaturated fatty acids, transition metals and
oxygen and poor antioxidant defenses render neuronal cells highly
vulnerable to reactive oxygen species (ROS) [12]. This culminates in
neuronal death [13], which may underlie the pathophysiology of neu-
rodegenerative diseases, stroke, and diabetes complications affecting
the CNS [12,14]. Insulin was previously reported to protect against
hydrogen peroxide (H2O2)- and serum deprivation-induced neuronal
apoptosis [15]. Thus, effects of oxidative stress on neuronal IR/IGF-1R
signaling inﬂuence brain function, impairing glucose metabolism and
leading to neuronal apoptosis [4]. Interestingly, brain insulin levels
appear to correlate with oxidative stress, type 2 diabetes mellitus and
Alzheimer's disease (AD) [16].
We have previously demonstrated that insulin protects against
oxidative stress-mediated neuronal damage [17]. Furthermore, insu-
lin stimulated glucose uptake and metabolism upon ascorbate/Fe2+,
Fig. 1. Analysis of immunocytoﬂuorescence and tyrosine phosphorylation activity of IR (A,C) and IGF-1R (B,D) in cultured cortical neurons. The cells were incubated in the absence or
presence of 0.1 and 10 µM insulin, incubated, respectively, for 48 h or immediately before, and also during and after the induction of oxidative stress,with ascorbate plus Fe2+ (Asc/Fe2+).
Immunocytoﬂuorescence was performed using antibodies against the β-subunits of IR (A) or IGF-1R (B) and anti-MAP2 to label differentiated neurons. IR and IGF-1R activities were
measured after immunoprecipitation of cytosolic extracts with rabbit anti-IR, β-subunit (C) or rabbit polyclonal anti-IGF-1Rβ (D) antibodies, followed by SDS/PAGE (10%) with mouse
monoclonal anti-P-Tyr. Results are themean±SEM of three independent experiments performed in duplicate (considering 139523.3 and 125190.6 INT/mm2 as 100% for IR and IGF-1R,
respectively). Statistical signiﬁcance: ⁎Pb0.05, ⁎⁎Pb0.01 vs Control; £Pb0.05 vs Asc/Fe2+ without insulin.
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be metabolized to uric acid [17]. Increased recycling of reduced
glutathione (GSH) (due to the stimulation of glutathione reductase
(GRed) and inhibition of glutathione peroxidase (GPx) activities) in-
duced by insulin also contributed to the replenishment of antioxidant
defenses [17]. Additionally, insulin neuroprotecion against oxidative
stress involved a decrease in extracellular adenosine [18]. Based on the
effect of selective inhibitors, protective effects of insulin under oxi-
dative stress appeared to be mediated by PI-3K and ERK signaling
pathways [17,18]. Thus, the aim of the current work was to investigate
the effect of insulin on IR- and IGF-1R-mediated intracellular signaling
pathways and the changes in the expression of “candidate” proteins
involved in the regulation of antioxidant defenses, energy metabolism
and apoptosis following oxidative stress in rat primary cortical neu-
rons. We demonstrate that activation of IR/IGF-1R mediate insulin
neuroprotection against oxidative stress through stimulation of PI-3K/
Akt and inhibition of GSK-3β, involving the regulation of protein
expression and neuronal survival.
2. Materials and methods
2.1. Materials
Insulin from porcine pancreas, protease inhibitors, anti-IR (β-subunit) and
-microtubule-associated protein 2 (MAP2), and 3-[(3-cholamidopropyl) dimethylam-
monio]-1-propane-sulfonate (CHAPS) were from Sigma-Chemical Co. (St. Louis, MO,
USA). Neurobasal Medium and B-27 supplement were from Gibco (Paisley, Scotland,
UK). Hoechst 33342, Alexa Fluor 594 anti-rabbit IgG, Alexa Fluor 488 anti-mouse IgG
and SuperScript™ III reverse transcription reagents were from Invitrogen (Eugene, OR,
USA). Protein A sepharose CL-4B, polyvinylidene diﬂuoride (PVDF) Hybond-P mem-Fig. 2. Insulin-mediated activation of Akt (A), ERK1/2 (B,C) and GSK-3β (D,E) signaling pa
analysed by western blotting with mouse anti-P-Akt (Ser473) monoclonal antibody, rabbit m
(Ser9) and mouse anti-P-GSK-3β (Tyr216). Then, the membranes were reprobed with rabbit
antibody, respectively. Results are the mean±SEM of three-seven independent experiments p
Akt, P-p44 ERK/total p44 ERK, P-p42 ERK/total p42 ERK, P-GSK-3β (Ser9)/total GSK-3β and P-
£Pb0.05, ££Pb0.01 vs Asc/Fe2+ in the absence of insulin.branes, anti-mouse and -rabbit IgG antibodies conjugated to alkaline phosphatase and
the Enhanced ChemiFluorescence reagent (ECF) were from Amersham Biosciences
(Little Chalfont, UK). Anti-α-tubulinwas from Zymed (San Francisco, CA, USA). Anti-IGF-
1Rβ (H-60) and -Bcl-2 (C-2) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA,
USA). Anti-P-Akt (Ser473), -P-p44/42 ERK (Thr202/Tyr204), -P-GSK-3β (Ser9), -p44/42
ERK and -caspase-3 were from Cell Signaling (Beverly, MA, USA). Anti-Akt, -P-GSK-3β
(Y216) and -total GSK-3β were from BD Biosciences (San Diego, CA, USA). Anti-type II
hexokinase (Hxk) and -glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were
from Chemicon International (Temecula, CA, USA). Anti-GPx-1 was from Abcam
(Cambridge, UK). RNeasy Mini Kit, QIAshredder spin columns, RNase-Free DNase Set,
and primers for Bcl-2 (Rn_Bcl2_1_SG QuantiTect Primer Assay), caspase-3
(Rn_Casp3_1_SG QuantiTect Primer Assay), GPx-1 (Rn_Gpx1_1_SG QuantiTect Primer
Assay), Hxk-II (Rn_Hk2_1_SG QuantiTect Primer Assay), β-actin (Rn_Actb_1_SG
QuantiTect Primer Assay) and β-2-microglobulin (Rn_B2m_1_SG QuantiTect Primer
Assay), and QuantiTect® SYBR Green PCR Master Mix were from Qiagen (Hilden,
Germany). N-acetyl-Asp-Glu-Val-Asp-p-nitroanilide (Ac-DEVD-pNA) was from Calbio-
chem (Darmstadt, Germany). RNA NanoLabChip (RNA 6000 Nano Assay) and DNA 1000
LabChip Kit were from Agilent Technologies (Santa Clara, CA, USA). All other reagents
were of the highest grade of purity commercially available.
2.2. Primary culture of cortical neurons
Pregnant female Wistar rats were obtained from our local colony (Animal Facilities,
Faculty of Medicine, University of Coimbra). Animals were kept under controlled light
and humidity conditions, being anesthesized under halothane atmosphere before
sacriﬁce by cervical displacement and decapitation (EU guideline 86/609/EEC). Cortical
neurons were isolated from brains of 15–16 day-old rat embryos, using a previously
described procedure [17]. Cells were maintained in Neurobasal Medium supplemented
with 2% B-27, 0.2 mM glutamine, 100U/ml penicillin, and 100mg/ml streptomycin and
cultured for 6 days in 95% air and 5% CO2. Cortical neurons were plated on poly-L-lysine
(0.1mg/ml) plates, at 3.1 × 105–2.5 × 106 cells/cm2, according to the experimental
procedures. Cortical cultures contained few glial cells (less than 10%), as assessed by
immunoﬂuorescence using anti-MAP2 and anti-GFAP (glial ﬁbrillary acidic protein)
[Almeida and Rego, unpublished data].thways. Intracellular activation of PI-3K/Akt/GSK-3β or ERK signaling pathways were
onoclonal anti-P-p44/42 ERK (Thr202/Tyr204) antibody, rabbit polyclonal anti-P-GSK3β
polyclonal anti-Akt antibody, rabbit polyclonal p44/42 ERK antibody and mouse GSK-3β
erformed in duplicate (considering 0.52, 0.92, 0.62, 0.69 and 0.92 as 100% for P-Akt/total
GSK-3β (Tyr216)/total GSK-3β, respectively). Statistical signiﬁcance: ⁎Pb0.05 vs Control;
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As previously reported [17,18], 0.1 or 10 μM insulin was added to Neurobasal
medium, 48 h (at 4 days in vitro, renewed every 24 h) or immediately (at 6 days in vitro)
before induction of oxidative stress with 1.5 mM ascorbic acid and 7.5 μM FeSO4, for
15 min, at 37 °C, in sodium saline solution, containing (in mM): 132.0 NaCl, 4.0 KCl,
1.2 Na2HPO4, 1.4 MgCl2, 1.0 CaCl2, 6.0 glucose and 10.0 HEPES, pH 7.4. Cells were further
incubated for 5h in Neurobasal medium in the absence of the oxidizing agents. Insulin
was present throughout the experiments. Ascorbate and Fe2+ solutions were prepared
immediately before use and maintained at 0–4 °C, protected from light.
2.4. IR and IGF-1R immunocytoﬂuorescence
Neurons were washed twice with saline buffer (PBS, in mM: 137 NaCl, 2.7 KCl,
1.4 K2HPO4, 4.3 KH2PO4, pH 7.4), and ﬁxed in 4% paraformaldehyde containing 4%
sucrose for 15 min. Cells were then permeabilized with 0.2% Triton X-100 for 2 min and
blocked in 3% BSA for 90 min. Permeabilized cells were then co-incubated with rabbit
anti-IR (β-subunit) or anti-IGF-1R (β-subunit) (10 μg/ml or 1:200, in 3% BSA, re-
spectively), andmouse anti-MAP2 (1:500, in 3% BSA), for 60min at room temperature. IR
or IGF-1R and MAP2 were detected by using the secondary antibodies Alexa Fluor 594
anti-rabbit IgG (1:100in 3% BSA) and Alexa Fluor 488 anti-mouse IgG (1:200 in 3% BSA),
respectively, incubated for 60 min. Nuclei were stained with Hoechst 33342 (2 μg/ml, in
PBS) for 5 min, protected from light. Fixed cells were treated with DakoCytomation
Fluorescentmounting solution on amicroscope slide, and neuronswere visualized in an
epiﬂuorescence Axiovert 200 ﬂuorescence microscope (Zeiss Axioscope, Zeiss,
Germany).
2.5. Immunoprecipitation of IR and IGF-1R
After incubation, neurons were scraped with immunoprecipitation buffer (IPB)
containing (in mM): 20 Tris–HCl, 100 NaCl, 2 EDTA and 2 EGTA, pH 7.0, supplemented
with 1% SDS, 50 mM NaF, 1 mM sodium o-vanadate, 0.1 μM okadaic acid, 1 mM DTT,
100 μM PMSF and 1:1000 of protease inhibitors cocktail (containing chymostatin,
pepstatin A, leupeptin, and antipain,1mg/ml). Themixturewas homogenized in 1:5 IPB,
containing 1% Triton X-100, at 0–4 °C, and centrifuged at 2500 rpm for 12 min in an
Eppendorf 5415C centrifuge, to remove the nuclei. The resulting supernatant was col-
lected and the pellet resuspended in IPB, and centrifuged again at 2500 rpm for 12 min.Fig. 3. Relative gene expression of GPx-1 (A), Hxk-II (B), Bcl-2 (C) and caspase-3 (D) upon tre
Qiagen RNeasy Mini Kit. Single-stranded cDNAwas synthesized by incubating 50 ng/µl of RN
time RT-PCR. Ampliﬁcation reaction mixture contained the cDNA sample, 2× QuantiTect® SY
levels of the target genes were normalized to the housekeeping genes β-actin and β-2-mic
duplicate. Statistical signiﬁcance: ⁎Pb0.05 vs Control; £Pb0.05, ££Pb0.01 vs Asc/Fe2+ in theThe supernatant was added to the previous one and protein content was determined
using the BioRad reagent.
Immunoprecipitation of neuronal cytosolic extracts (100 μg) was performed as
previously described [17]. Brieﬂy, cytosolic extracts were mixed with a slurry of protein A
sepharose beads (1:1, in IPB), for 1 h at 4 °C. Simultaneously, a slurry of protein A sepharose
beads were mixed with 5 μl of rabbit anti-IR (β-subunit) or anti-IGF-1Rβ in IPB plus 1%
Triton X-100, for 2 h, at 4 °C. Mixtures were centrifuged at 14,000 rpm, 0–4 °C, for 10 min.
The supernatant of the ﬁrst mixture was recovered and incubated with IR or IGF-1R
antibodies covalently cross-linked to protein sepharose A (pellet) for 4 h, at 4 °C. Immune
complexes were then centrifuged at 14,000 rpm, 10 min, and the pellet was washed with
IPB. Finally, the immune complexes were denatured with SDS sample buffer, containing
0.5M Tris–HCl, 0.4% SDS, pH 6.8, supplemented with 30% glycerol, 10% SDS, 0.6M DTT and
0.012% bromophenol blue, at 100 °C, for 5min, and then centrifuged at 14,000 rpm,10min,
using Spin-X® centrifuge tube ﬁlter to separate the protein A sepharose beads.
2.6. Western blotting
After incubation, neurons were scraped with buffered solution containing (in mM):
250 sucrose, 20 HEPES, 10 KCl, 1.5 MgCl2, 1 EDTA, and 1 EGTA, pH 7.4, supplemented as
described for the preparation of immunoprecipitation samples.
Samples containing immunoprecipitated denatured proteins or the subcellular
suspension were immediately subjected to SDS/PAGE (10%) analysis and transferred
onto PVDF Hybond-P membranes. Membranes containing immunoprecipitated IR and
IGF-1R were incubated with mouse anti-P-Tyr (1:1000), overnight at 4 °C. Membranes
containing subcellular proteins were incubated with mouse P-Akt (Ser473) (1:1000),
rabbit P-p44/42 ERK (Thr202/Tyr204) (1:1000), mouse P-GSK-3β (Tyr216) (1:1000),
mouse Bcl-2 (1:200), rabbit caspase-3 (1:1000), rabbit GPx-1 (1:200) and rabbit Hxk-II
(1:5000) antibodies. Membranes were reprobed with rabbit Akt (0.40 μg/ml), rabbit
p44/42 ERK (1:1000), rabbit P-GSK3β (Ser9) (1:1000) and mouse GSK-3β antibo-
dies (1:2500), respectively. Membranes were also labelled withmouse GAPDH (1:2000)
or α-tubulin (1:2500) antibodies (in the case of caspase-3 labelling due to the proximity
of molecular weights). Membranes were then incubated with anti-rabbit and anti-
mouse IgG secondary antibodies (1:25,000), for 2 h at room temperature, and developed
using ECF. Immunoreactive bands were visualized by the VersaDoc Imaging System
(BioRad, Hercules, CA, USA). Fluorescence signal was analysed using the QuantityOne
software and the results were given as INT/mm2. Phosphorylated protein/total pro-
tein and protein expression levels, corresponding to the ratio of each protein vs GAPDH
or α-tubulin, were expressed as % of control.atment with insulin. Total RNA was extracted from cortical neuronal cultures using the
A with SuperScript™III reverse transcription reagents. The mRNAwas analysed by real-
BR Green PCR Master Mix, QuantiTect® Primer Assay and RNase-free water. The mRNA
roglobulin. Results are the mean±SEM of ﬁve independent experiments performed in
absence of insulin.
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Total RNAwas extracted using the RNeasyMini kit, according to the manufacturer's
protocol. After incubation, cortical neurons were rapidly scrapped with diluted RLT
buffer, containing β-mercaptoethanol (10μl/ml), collected into RNase- and DNase-free
eppendorf tubes and stored immediately at −80 °C. Furthermore, RNA samples were
treated with RNase-Free DNase set, according to manufacturer's instructions, to remove
any residual genomic DNA. RNA sample was diluted in RNase-free water and the sam-
ples were stored at −80 °C.
RNA integrity of randomly chosen samples was analyzed in an Agilent 2100 Bio-
analyzer using a RNA NanoLabChip (RNA 6000 Nano Assay) and RNA integrity numbers
(RIN) were greater than 7 in all analyzed samples. Single-stranded cDNA was syn-
thesized using SuperScript™ III reverse transcription reagents, by incubating total RNA
(50 ng/μl of DNase-treated RNA) with 2.5 ng/μl random hexamers, 0.5 mM dNTP mix
and RNase-freewater, for 5min at 65 °C. Then, RNA/primermixwas incubated in a Gene
Amp PCR System 9600 thermocycler (Perkin-Elmer, Wellesley, MA, USA) for 10 min at
25 °C with cDNA synthesis mix containing 10 mM DTT, 2 U/μl RNase OUT, 10 U/μl
SuperScript™ III reverse transcriptase and FS buffer. cDNA synthesis occurred at 50 °C
for 50 min and reactionwas stopped by inactivation of reverse transcriptase at 85 °C for
5 min. Samples were incubated for 20 min at 37 °C with RNase H.
2.8. Real-time RT-PCR
Real-time RT-PCR was performed to monitor the expression of Bcl-2, Caspase-3
(Casp3), GPx1 and Hxk-II, and of the endogenous control genes β-actin (Actb) and β-2-
microglobulin (B2m). The HotStarTaq DNA Polymerase technology was used and the
results were analyzed in a 7900 HT sequence detector system (Applied Biosystems,
Foster City, CA, USA).
Ampliﬁcation reaction mixture contained cDNA sample, QuantiTect® SYBR Green
PCR Master Mix, QuantiTect® Primer Assay and RNase-free water. For real-time PCR,
each mixture was added to 96-well optical reaction plate. For control purposes, non-
template samples were subjected to PCR ampliﬁcation. Thermal cycling conditions
included 10min at 95 °C, proceeding with 40 cycles of 95 °C for 15 s and 60 °C for 1 min.
The size of the PCR product was determined in an Agilent 2100 bioanalyzer using a DNA
1000 LabChip Kit. mRNA levels of the target genes were normalized to that of the
geometric mean of endogenous control genes Actb and B2m, and expressed relative to
control in the absence of insulin using the ΔΔCt method.Fig. 4. GPx-1 (A), Hxk-II (B), Bcl-2 (C) and procaspase-3 (D) protein expression levels in co
blotting with rabbit polyclonal GPx-1, rabbit type II Hxk, mouse Bcl-2 (C-2) monoclonal, rab
antibodies. Results are the mean±SEM of three-seven independent experiments performe
GAPDH, Bcl-2/GAPDH and procaspase-3/α-tubulin, respectively). Statistical signiﬁcance: ⁎P2.9. Colorimetric evaluation of caspase-3-like activity
Caspase-3-like activitywasdetermined by following a previously describedprocedure
[19]. Brieﬂy, 25 μg protein were added to a reaction buffer containing 25 mM HEPES, 10%
sucrose, 0.1%CHAPS, pH7.5, supplementedwith 10mMDTTand colorimetric substrateAc-
DEVD-pNA (100 μM). After incubation at 37 °C for 2 h, formation of pNAwas measured at
405 nm in a Synergy™-HT Multidetection Microplate Reader (Bio-Tek®Instruments, Inc,
Winooski, VT, USA). Caspase-3-like activity was calculated as the increase above the
control for equal protein loads, and the results expressed in % of control.
2.10. Assessment of apoptotic neurons
Apoptotic cells were characterized using the ﬂuorescent probe Hoechst 33342.
Brieﬂy, 24 h after oxidative stress, cells were loaded with 15 μg/ml Hoechst 33342 in
PBS, for 15 min at 37 °C. Cells (viable and apoptotic) were visualized using an
epiﬂuorescence Axiovert 200 ﬂuorescence microscope. Condensed/fragmented (apop-
totic) nuclei were markedly bright and small or divided into several chromatin clumps
after staining with Hoechst 33342. Viable cells showed diffuse Hoechst labeling.
2.11. Data analysis and statistics
Results are expressed as mean ± SEM of the indicated number of independent
experiments, run in duplicates or triplicates. Statistical signiﬁcance was analyzed using
one-way-ANOVA for multiple comparisons, with Bonferroni post-test. Pb0.05 was
considered signiﬁcant.
3. Results
3.1. Insulin prevents the inhibition of neuronal IR and IGF-1R activity
upon exposure to ascorbate/Fe2+
Immunocytoﬂuorescence revealed a co-localization of both IR and
IGF-1Rwithanti-MAP2 labeling, suggesting that both receptors arewidely
spread throughout cultured cortical neurons (Fig. 1A,B). Exposure to
ascorbate/Fe2+ did not affect the distribution of both receptors (Fig. 1A,B).rtical neurons subjected to insulin treatment. Cell extracts were analysed by western
bit polyclonal caspase-3, mouse monoclonal GAPDH and mouse monoclonal α-tubulin
d in duplicate (considering 0.72, 0.91, 1.29 and 1.82 as 100% for GPx-1/GAPDH, Hxk-II/
b0.05 vs Control; £Pb0.05, ££Pb0.01, £££Pb0.001 vs Asc/Fe2+ without insulin.
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kinase activity and initiating intracellular signaling pathways [7].
Although insulin (0.1 and 10 μM) per se rapidly activated IR and IGF-1R
after incubation for 10 or 30 min (particularly for 10 μM) (data not
shown), we did not observe a signiﬁcant activation of these receptors
upon longer incubation periods used throughout this study (Fig. 1C,D).
Nevertheless, insulin signiﬁcantly prevented oxidative stress-induced
decrease in Tyr phosphorylation of both receptors (Fig. 1C,D),
suggesting the restoration of IR and IGF-1R activities.
3.2. Insulin modulates intracellular PI-3K/Akt and GSK-3β signaling
pathways upon oxidative stress
Following our previous results, we further analysed the role of
insulin on the phosphorylation of Akt, ERK and GSK-3β (Fig. 2A–E).
Although insulin per se had no signiﬁcant effect on P-Akt, con-
cordantly with no changes in receptor activity (Fig. 1C,D), it prevented
the decrease in P-Akt associated with oxidative stress (Fig. 2A),
suggesting that PI-3K/Akt signaling plays an important role on insulin-
mediated effects on cortical neurons. It should be noted that, under
control conditions, exposure to 0.1 or 10 μM insulin for 10 or 30 min
increased P-Akt (data not shown).Fig. 5. Apoptotic neuronal death in cortical neurons treated with insulin. Apoptosis w
condensation/fragmentation (B). Caspase-3-like activity was determined by following the
ﬂuorescent probe Hoechst 33342. Results are the mean±SEM of ﬁve-ten independent exp
⁎⁎Pb0.01 vs Control; ££Pb0.01, £££Pb0.001 vs Asc/Fe2+ in the absence of insulin. In (B) are
10 µM insulin (Ins0.1 and Ins10, respectively), visualized in an inverted Nikon Diaphot ﬂuoRas activates Raf-1, which sequentially phosphorylates and acti-
vates MEK and ERK1/2 [9]. However, neither P-ERK p44 nor P-ERK p42
was signiﬁcantly affected by insulin (0.1 and 10 μM) or ascorbate/Fe2+
(Fig. 2B,C).
Phosphorylation of GSK-3β on Ser9 inhibits its activity, whereas at
Tyr216 activates the enzyme [20]. We also evaluated the involvement
of GSK-3β on insulin neuroprotection (Fig. 2D,E). Neither insulin nor
ascorbate/Fe2+ changed signiﬁcantly the levels of GSK-3β phosphory-
lated on Ser9 (Fig. 2D). No signiﬁcant changes were observed in the
phosphorylation of Tyr216 upon oxidative stress either (Fig. 2E).
Interestingly, insulin (0.1 and 10 μM) decreased GSK-3βTyr216
phosphorylation, the active form of GSK-3β, by about 26%, particularly
in the presence of ascorbate/Fe2+ (Fig. 2E).
3.3. Insulin regulates mRNA and protein expression levels of “candidate”
proteins upon oxidative stress
Following our previous data [17,18], we analysed the role of insulin
on the expression of “candidate” proteins involved in these pathways,
namely GPx-1, Hxk-II, Bcl-2 and caspase-3 (Figs. 3 and 4).
Upon ascorbate/Fe2+ exposure, both 0.1 and 10 μM insulin pre-
vented the increase in GPx-1 and caspase-3 mRNA levels (Fig. 3A,D).as analysed by the activation of the effector caspase-3 (A), and by assessing DNA
extent of cleavage of Ac-DEVD-pNa, at 405 nm, whereas DNA was analysed with the
eriments performed in duplicate (considering 0.015 as 100%). Statistical signiﬁcance:
representative images of viable and apoptotic neurons upon treatment with 0.1 and
rescence microscope.
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Hxk-II and Bcl-2 mRNA expression levels (Fig. 3B,C). These results
suggested that insulin-mediated activation of intracellular signaling
pathways under oxidative stress conditions culminated in the
regulation of gene expression, thus affecting subsequent protein ex-
pression. To further test this hypothesis, we measured the expression
levels of the “candidate” proteins GPx-1, Hxk-II, Bcl-2 and procaspase-
3 by western blotting (Fig. 4A–D). Similarly to the results shown in
Fig. 3, insulin (0.1 and 10 μM) completely prevented the increase in
GPx-1 (Fig. 4A) and procaspase-3 (Fig. 4D) and the decrease in Hxk-II
(Fig. 4B) and Bcl-2 (Fig. 4C) protein expression induced by ascorbate/
Fe2+. Insulin per se did not signiﬁcantly affect the mRNA or protein
expression levels of these “candidate” proteins.
Hence, insulin neuroprotection against oxidative stress may
involve the regulation of the expression of genes and proteins in-
volved in glutathione redox cycle, glycolytic energy metabolism and
anti-apoptotic processes.
3.4. Insulin protects against apoptosis under oxidative stress
Since insulin stimulates Bcl-2 expression (Figs. 3C and 4C) and
inhibits caspase-3 expression (Figs. 3D and 4D), we further investi-
gated its effects on caspase-mediated apoptosis, by determining
caspase-3 activity and DNA fragmentation (Fig. 5A,B). We observed
that ascorbate/Fe2+-induced increase in caspase-3 activity (by about
52%) was completely prevented by 0.1 and 10 μM insulin. No changes
were induced by insulin per se (Fig. 5A). These results were further
corroborated by the observation that oxidative stress-mediated DNA
fragmentation was prevented by insulin (Fig. 5B).
Data suggest that, by activating IR/IGF-1R signaling pathways,
insulin rescues cortical neurons from caspase-3-mediated apoptotic
cell death.
4. Discussion
Recent hypothesis suggest that insulin and IGF-1 can be the
missing link between diabetes and AD, and possibly other neurode-
generative diseases, for which oxidative stress has been extensivelyFig. 6. Stimulation of IR/IGF-1R-induced PI-3K/Akt signaling pathway mediates insulin ne
conditions induces the phosphorylation of IR and/or IGF-1R, whichmaintains the activation o
proteins, namely GPx-1, Hxk-II, Bcl-2 and caspase-3, thus helping to counterbalance oxidat
with GSK-3β signaling, decreasing its activated form and inhibiting apoptotic neuronal death
hexokinase-II; GSH, reduced glutathione; GSSG, oxidized glutathione.described [16]. Thus, deleterious effects induced by oxidative stress on
neuronal IR/IGF-1R signaling are related with altered brain function.
In the present study, we analysed the involvement of IR/IGF-1R
intracellular signaling pathways on insulin neuroprotection against
oxidative stress [17,18]. Both IR and IGF-1R were present in cortical
neurons, in agreement with other reports [5,21]. Although rat brain IR
mRNA is most abundant at embryonic day 20 and at birth, paralleling
the changes observed in insulin binding and IR density [22], the
duration of IR activation remains uncertain. Insulin-mediated neuro-
nal IR activation phosphorylates IRS-2 within 2–5 min, with a peak at
20–30min [23,24], further phosphorylating PI-3K. Neuronal Akt, GSK-
3β, ERK1/2 and FoxO1 were also maximally phosphorylated in re-
sponse to IR activation 10 min after peripheral insulin injection [24].
This was not observed in NIRKO mice, a neuronal/brain-speciﬁc IR
knockout [24] or upon wortmannin exposure [8]. Therefore, it is not
surprising that insulin per se did not show IR or IGF-1R Tyr
phosphorylation under our experimental conditions, since the short-
est time-interval for insulin exposure of cortical neurons exceeds 5h.
Nevertheless, Huang et al. [25] showed that insulin can induce a long-
lasting (30 h, 1 nM) PI-3K-dependent phosphorylation of Akt, in
cultured adult sensory neurons. Unlike peripheral IR, brain IR is not
downregulated upon exposure to high insulin levels [26], supporting
insulin-mediated effects upon ascorbate/Fe2+.
In this study, ascorbate/Fe2+-induced caspase-3 activation was ac-
companied by a decrease in Bcl-2 expression, suggesting that caspase-
3 mediates apoptotic neuronal death under oxidative stress, support-
ing our previous observations [17]. This agrees with the observation
that ROS-induced mitochondrial dysfunction may result in mitochon-
drial cytochrome c release, apoptosome activation, caspase-3 cleavage
and apoptosis [27].
PI-3K/Akt regulates the survival response against oxidative stress-
associated neuronal apoptosis [28]. In the present study, ascorbate/Fe2+
neurotoxicity occurred via inhibition of both IR and IGF-1R, leading to
impairment of Akt phosphorylation. Insulin neuroprotection against
oxidative stress involved the stimulation of IR and IGF-1R activity and
the restoration of PI-3K/Akt signaling pathway. Neuroprotection can be
further afforded by phosphorylation of GSK-3β at Ser9, which becomes
inactive, as occurs in primary cultured neurons and in the hippocampaluroprotection against oxidative stress. Treatment with insulin under oxidative stress
f the PI-3K/Akt signaling pathway. This appears to regulate the expression of “candidate”
ive stress, impaired glucose metabolism and neuronal apoptosis. Insulin also interferes
under oxidized conditions. Casp-3, caspase-3; GPx-1, glutathione peroxidase-1; Hxk-II,
1001A.I. Duarte et al. / Biochimica et Biophysica Acta 1783 (2008) 994–1002HT22 neurons [29]. As a consequence, GSK-3β-induced inhibition of
heat shock factor-1 [30] and CREB activity is abolished, stimulating Bcl-2
expression [11] and protecting against caspase-3-dependent and
-independent neuronal apoptosis [31]. Conversely, stimulation of GSK-
3β activity due to chronic inhibition of insulin signaling caused apop-
tosis involving oxidative and endoplasmic reticulum stress [32–34].
Despite no changes in phosphorylation of GSK-3βSer9 (inactive) in the
present study, insulin decreased GSK-3βTyr216 (active) phosphoryla-
tion. Oxidative stress did not interfere with GSK-3β phosphorylation,
suggesting that its deleterious effects may involve other mechanisms,
namely decreased phosphorylation of Bad [14]. Although less investi-
gated, inhibition of GSK-3βTyr216 phosphorylation in neurons can be
involved in insulin stimulation of Bcl-2 expressionuponoxidative stress.
Indeed, under oxidative stress, insulin prevented changes in expression
of genes linked to cell survival, namely Bcl-2 and caspase-3.
We previously showed that ascorbate/Fe2+ impaired neuronal
glucose uptake and metabolism [18], which was accounted for by an
increased oxidation of GLUT3 transporter by 4-hydroxynonenal [17].
Decreased Hxk-II levels induced by oxidative stress, as observed in the
present study, may further contribute to glycolysis inhibition and
lower intracellular ATP levels [18]. Hxk-II represents the rate-limiting
step in neuronal glycolysis — the formation of glucose-6-phosphate
[35], being also a downstream effector of Akt-mediated cell survival in
rat ﬁbroblasts [36]. Thus, stimulation of Hxk-II expression by insulin
correlates with the increase in glucose metabolism and intracellular
ATP and adenosine levels upon oxidation [18].
Here we show that exposure to ascorbate/Fe2+ increased GPx-1
mRNA and protein expression, which correlates with increased GPx
activity [17], thus contributing to glutathione redox cycle impairment.
Since GPx-1 is the main neuronal antioxidant enzyme in the cytosol
and mitochondria [37], insulin-induced decrease in expression and
activity of GPx-1 may contribute to the replenishment of antioxidant
defenses under oxidative stress [17].
Neuronal IR and IGF-1R can also activate ERK1/2 signaling, thus
modulating gene expression [38]. H2O2 may activate MEK-ERK1/2
signaling, stimulating neuronal gene expression [28] or protecting
against acute neuronal apoptosis [39]. Although ERK1/2 signaling
cascade was unmodiﬁed in our experimental conditions, we cannot
exclude its involvement in insulin effects against oxidation-mediated
injury. Indeed, we previously observed that insulin-mediated protec-
tive effects under oxidative stress were precluded in the presence of
the MEK inhibitor PD98059. This inhibitor altered the levels of in-
tracellular uric acid, ATP and adenosine, highly suggesting the in-
volvement of the ERK1/2 pathway [17,18]. The apparent discrepancy
may be explained by the fact that ERK1/2 signaling was determined at
the end of the experiments, whereas PD98059 was incubated prior to
insulin exposure.
In summary, we demonstrate that insulin neuroprotection against
oxidative stress is mediated by IR- and/or IGF-1R-induced activation of
PI-3K/Akt and inhibition of GSK-3β signaling pathways, which appear
to modulate the expression of proteins involved in glucose metabo-
lism (Hxk-II), antioxidant defenses (GPx-1) and anti-apoptotic mech-
anisms (Bcl-2 and caspase-3) under ascorbate/Fe2+ treatment, thus
protecting cortical neurons against caspase-3-dependent apoptosis
(Fig. 6). These results are in agreement with insulin stimulation of
neuronal glucose uptake and metabolism, the increase in intracellular
ATP, adenosine, uric acid and glutathione redox cycle and the decrease
in lipid and protein oxidation upon oxidative stress [17,18] (Fig. 6).
These data are important, since oxidative stressmay be themissing
link between the loss of β-pancreatic cells and neurons that underlies
type 2 diabetes and AD [2,40]. AD has been considered “brain-type
diabetes” [16] and insulin may constitute a therapeutic agent against
AD via activation of neuronal IR/IGF-1R signaling pathways. Never-
theless, systemic insulin administration in AD should avoid hypergly-
cemia-associated cognitive and memory deﬁcits [41]. According to
Reger et al. [42], this limitation can be circumvented by intranasalinsulin administration, allowing its direct entry into the brainwithout
affecting peripheral glucose or insulin levels.
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